Product
Streak Silencer, and what comes after it
Product line 01 targets Cassava Brown Streak Disease. The platform behind it is designed to be retargeted.
Product line 01
Streak Silencer
Product line 01: commercial bioprotection against CBSD root necrosis.
- Who it is for
- Aggregated commercial outgrower blocks supplying regional industrial starch processors.
- Formulation
- Aqueous LDH nanocrystal suspension carrying CBSD-targeted dsRNA.
- Operating goal
- Hold weighbridge rejection below 5% across a contracted supply corridor.
- Commercial model
- Per-hectare protection contracted through the processor, not sold retail to smallholders.
Pipeline
One platform, many targets
The delivery system stays constant. Only the sequence changes.
- Streak SilencerActive
Cassava brown streak. Sequence motifs matched to UCBSV isolates.
- Next targetQueued
The same delivery platform, retargeted to the next regional viral threat.
Working with us
How a deployment starts
We are pre-commercial. These are the three ways an organisation can engage with KaaraGen today.
Validation partner
For research institutions and labs
Co-run bench-scale validation on synthesis, encapsulation and UV stability.
- Shared wet lab protocols
- Access to in silico target parameters under NDA
- Named on resulting validation data
Pilot corridor
For starch processors and cooperatives
A controlled 10-hectare deployment in your supply corridor with an audited control comparison.
- Both application protocols trialled
- Audited starch extraction rate vs untreated control
- Weighbridge rejection tracked through the season
- First right of refusal on commercial supply
Platform partnership
For investors and strategic partners
Back the delivery platform rather than a single product line, and help set the next target.
- Full technical and commercial data room
- Roadmap and milestone reporting
- Input on pipeline target selection
Secure your supply corridor before the next harvest.
If you run a processing facility, fund early biotech, or work on cassava in East Africa, we would like to hear from you.
Request the technical brief